M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
Current era minimally invasive aortic valve replacement: Techniques and practice
S. Chris Malaisrie,Glenn R. Barnhart,R. Saeid Farivar,John R. Mehall,Brian W. Hummel,Evelio Rodriguez,Mark Anderson,Clifton T. P. Lewis,Clark W. Hargrove,Gorav Ailawadi,Scott M. Goldman,Junaid H. Khan,Michael G. Moront,Eugene A. Grossi,Eric E. Roselli,Arvind K. Agnihotri,Michael J. Mack,J. Michael Smith,Vinod H. Thourani,Francis G. Duhay,Mark T. Kocis,William H. Ryan +21 more
TL;DR: Improved cosmesis, less pain and narcotic use, and faster recovery have been reported and generally accepted by patients and by surgeons performing minimally invasive aortic valve replacement, and these benefits are more likely to be verified with standardization of the procedure itself.
Journal ArticleDOI
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience.
Neil Fam,Ralph Stephan von Bardeleben,Mark Hensey,Susheel Kodali,Robert L. Smith,Jörg Hausleiter,Geraldine Ong,Robert H. Boone,Tobias Ruf,Isaac George,Molly Szerlip,Michael Nabauer,Faeez M. Ali,Robert Moss,Vinayak Bapat,Katharina Schnitzler,Felix Kreidel,Jian Ye,Djeven P. Deva,Michael J. Mack,Paul A. Grayburn,Mark D. Peterson,Martin B. Leon,Rebecca T. Hahn,John G. Webb +24 more
TL;DR: In this article, the feasibility and safety of the EVOQUE tricuspid valve replacement system and its impact on short-term clinical outcomes was investigated in a first-in-human experience.
Journal ArticleDOI
Diagnosing the indeterminate pulmonary nodule: Percutaneous biopsy versus thoracoscopy
Surindra N. Mitruka,Rodney J. Landreneau,Michael J. Mack,Lynda S. Fetterman,James S. Gammie,Susan Bartley,Shannon R. Sutherland,Claudia M. Bowers,Robert J. Keenan,Peter F. Ferson,Robert J. Weyant +10 more
TL;DR: Limited accuracy for benign Dx with CT-Bx requires surgical biopsy for patients with SPN with adequate physiologic reserve, and Thor-BX is a safe and accurate minimally invasive surgical approach to resectable peripheral SPN.
Journal ArticleDOI
Bypass Versus Drug-Eluting Stents at Three Years in SYNTAX Patients With Diabetes Mellitus or Metabolic Syndrome
Michael J. Mack,Adrian P. Banning,Patrick W. Serruys,Marie-Claude Morice,Yves Taeymans,Guido Van Nooten,Gianfederico Possati,Filippo Crea,Kristin L. Hood,Katrin Leadley,Keith D. Dawkins,A. Pieter Kappetein +11 more
TL;DR: Although PES is a potential treatment option in patients with less complex lesions, CABG should be the revascularization option of choice for patients with more complex anatomic disease, especially with concurrent diabetes.
Journal ArticleDOI
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure
Michael J. Mack,JoAnn Lindenfeld,William T. Abraham,Saibal Kar,D. Scott Lim,Jacob M. Mishell,Brian Whisenant,Paul A. Grayburn,Michael Rinaldi,Samir R. Kapadia,Vivek Rajagopal,Ian J. Sarembock,Andreas Brieke,Jason H. Rogers,Steven O. Marx,David J. Cohen,Neil J. Weissman,Gregg W. Stone,Coapt Investigators +18 more
TL;DR: In the COAPT trial, transcatheter mitral valve repair (TMVr) resulted in fewer heart failure hospitalizations (HFHs) and lower mortality at 24-months in patients with heart failure (HF) with mitral regurgitation (MR) secondary to left ventricular dysfunction compared with guideline-directed medical therapy (GDMT) alone as mentioned in this paper.